Testing 9MW1911 for people with moderate to severe COPD
Part of Lungs & breathing clinical trials.
This trial tests a new medication called 9MW1911 to see if it can help people with moderate to severe COPD who have had recent flare-ups. It is for current or former smokers ages 40 to 75 who are already on standard COPD treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 40 and 75 years old.
- You have had COPD for at least 1 year.
- You have had at least 2 moderate or 1 severe COPD flare-up in the last year.
- Your lung function test shows airflow limitation (FEV1/FVC less than 0.7 and FEV1 between 20% and 80% of predicted).
- You are a current or former smoker with a history of smoking at least 10 pack-years (e.g., 1 pack a day for 10 years).
- You have been on stable COPD medications for at least 1 month.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an experimental drug called BBT002 in healthy volunteers and people with chronic obstructive pulmonary disease (COPD), a lung condition that makes breathing hard. It aims to see if the drug is safe and how the body processes it.
This trial tests a new drug called AZD6793 for people with moderate to very severe COPD. It aims to see if the drug can help improve breathing and reduce flare-ups.
This study tests a new treatment for people with COPD who still have frequent flare-ups despite using two maintenance inhalers. It aims to see if the study medicine can reduce these flare-ups.
This trial tests an injection called RC1416 for people with moderate-to-severe COPD who still have flare-ups despite using triple inhaler therapy. It may help reduce those flare-ups and improve breathing.
This trial tests a new medicine called PF-07275315 for people with moderate to severe COPD. It aims to see if it can help reduce flare-ups (sudden worsening of symptoms) when added to your usual treatment.
This trial tests a new medicine called 611 for people with moderate to severe COPD. It aims to see if adding 611 to your current treatments can help prevent flare-ups and improve symptoms.
Hear when a new Chronic Obstructive Pulmonary Disease COPD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.